etoposide has been researched along with top 53 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, K; Kobunai, T; Oh-hara, T; Shibata, J; Sugimoto, Y; Terada, T; Tsuruo, T; Utsugi, T; Wierzba, K; Yamada, Y | 1 |
| Bandoh, T; Kitamura, R; Satoh, T; Tsuda, M | 1 |
| Aoyagi, K; Kobunai, T; Saito, H; Utsugi, T; Wierzba, K; Yamada, Y; Yoshida, M | 1 |
| Byl, JA; Cline, SD; Kobunai, T; Osheroff, N; Utsugi, T; Yamada, Y | 1 |
| Asai, T; Baba, K; Irimura, K; Oku, N; Shimizu, K; Takada, M | 1 |
| Malik, M; Nitiss, JL | 1 |
| Carr, AM; Hartsuiker, E; Neale, MJ | 1 |
7 other study(ies) available for etoposide and top 53
| Article | Year |
|---|---|
Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; DNA, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasms, Experimental; Specific Pathogen-Free Organisms; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1996 |
Determination of a new podophyllotoxin derivative, TOP-53, and its metabolite in rat plasma and urine by high-performance liquid chromatography with electrochemical detection.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Drug Stability; Electrochemistry; Etoposide; Glucuronates; Rats; Sensitivity and Specificity | 1997 |
Specific distribution of TOP-53 to the lung and lung-localized tumor is determined by its interaction with phospholipids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Etoposide; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Phospholipids; Quinidine; Tissue Distribution | 2000 |
DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; DNA Damage; DNA Ligases; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Fungal; Etoposide; Humans; Hydrolysis; Isoenzymes; Mutagenesis, Site-Directed; Recombinant Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2001 |
Potential usage of liposomal 4beta-aminoalkyl-4'-O-demethyl-4-desoxypodophyllotoxin (TOP-53) for cancer chemotherapy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Blood Vessels; Body Weight; Enzyme Inhibitors; Etoposide; Liposomes; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Survival Analysis; Topoisomerase II Inhibitors | 2002 |
DNA repair functions that control sensitivity to topoisomerase-targeting drugs.
Topics: Camptothecin; Cell Cycle; DNA Damage; DNA Repair; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Etoposide; Genotype; Mutation; Plasmids; Recombination, Genetic; Schizosaccharomyces; Sensitivity and Specificity; Temperature; Time Factors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; X-Rays | 2004 |
Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA.
Topics: Camptothecin; Cell Nucleolus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Fungal; Etoposide; Exodeoxyribonucleases; Gamma Rays; Methyl Methanesulfonate; Mutant Proteins; Mutation; Protein Binding; Schizosaccharomyces; Schizosaccharomyces pombe Proteins | 2009 |